Notice of Registration - 2012
[Federal Register Volume 77, Number 202 (Thursday, October 18, 2012)]
[Notices]
[Page 64143]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-25643]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances, Notice of Registration, Akorn,
Inc.
By Notice dated July 17, 2012, and published in the Federal
Register on July 26, 2012, 77 FR 43861, Akorn, Inc., 1222 W. Grand
Avenue, Decatur, Illinois 62522, made application to the Drug
Enforcement Administration (DEA) to be registered as an importer of
Remifentanil (9739), a basic class of controlled substance listed in
schedule II.
The company plans to import Remifentanil in bulk for use in dosage-
form manufacturing.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and 952(a), and determined that the
registration of Akorn, Inc., to import the basic class of controlled
substance is consistent with the public interest, and with United
States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971. DEA has investigated Akorn Inc., to
ensure that the company's registration is consistent with the public
interest. The investigation has included inspection and testing of the
company's physical security systems, verification of the company's
compliance with state and local laws, and a review of the company's
background and history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the above named company is granted
registration as an importer of the basic class of controlled substance
listed.
Dated: October 9, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2012-25643 Filed 10-17-12; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |
